Prevalence and sociodemographic determinants of dyspepsia in the general population of Rwanda.


Journal

BMJ open gastroenterology
ISSN: 2054-4774
Titre abrégé: BMJ Open Gastroenterol
Pays: England
ID NLM: 101660690

Informations de publication

Date de publication:
05 2020
Historique:
received: 12 02 2020
revised: 09 03 2020
accepted: 27 03 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 20 7 2021
Statut: ppublish

Résumé

Dyspepsia accounts for a significant burden of worldwide disease, but there is a relative paucity of data from the sub-Saharan African setting. We undertook to describe the burden, risk factors and severity of dyspepsia across Rwanda. We performed a population-based clustered cross-sectional survey between November 2015 and January 2016, nationwide in Rwanda, using the Short Form Leeds Dyspepsia Questionnaire to describe the presence and severity of dyspepsia, and the Short Form Nepean Dyspepsia Index to describe the concomitant quality of life effects. Univariate and multivariate logistic regression models were constructed to correlate measured sociodemographic factors with dyspepsia. The prevalence of clinically significant dyspepsia in the general Rwandan population was 14.2% (283/2000). The univariate factors that significantly predicted severity were gender, profession, socioeconomic status, and non-steroidal anti-inflammatory drug, aspirin and alcohol use, with gender, current smoking, aspirin use both in the past and currently, and alcohol use in the past remaining significant on multivariate modelling. Dyspeptics had a significantly lower gastrointestinal-related quality of life, though the sociodemographic factors measured did not modify the observed quality of life. Dyspepsia is prevalent in the Rwandan setting and is associated with a significant burden on quality of life. More work is required to determine the pathological entities involved, and the optimal approach to mitigating this burden.

Identifiants

pubmed: 32381743
pii: bmjgast-2020-000387
doi: 10.1136/bmjgast-2020-000387
pmc: PMC7222881
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Aspirin R16CO5Y76E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

East Afr Med J. 2002 May;79(5):232-6
pubmed: 12638805
BMC Gastroenterol. 2018 Jan 18;18(1):13
pubmed: 29347978
J Gastroenterol Hepatol. 2011 Nov;26(11):1669-76
pubmed: 21649731
Anat Rec (Hoboken). 2010 Sep;293(9):1536-42
pubmed: 20648573
Gut. 2015 Jul;64(7):1049-57
pubmed: 25147201
J Manag Care Pharm. 2013 Nov-Dec;19(9):755-64
pubmed: 24156644
Am J Gastroenterol. 1999 Sep;94(9):2390-7
pubmed: 10483997
World J Gastroenterol. 2009 Jul 7;15(25):3173-7
pubmed: 19575499
Eur J Gastroenterol Hepatol. 1995 Oct;7(10):985-7
pubmed: 8590146
Scand J Gastroenterol Suppl. 1999;231:29-37
pubmed: 10565621
BMJ Open. 2016 Jun 06;6(6):e011018
pubmed: 27266772
Turk J Gastroenterol. 2004 Jun;15(2):86-9
pubmed: 15334316
Am J Gastroenterol. 2004 Nov;99(11):2210-6
pubmed: 15555004
Ugeskr Laeger. 1982 Jan 25;144(4):267-73
pubmed: 7071969
Gastroenterology. 1981 Aug;81(2):376-94
pubmed: 7016659
Indian J Gastroenterol. 2001 May-Jun;20(3):103-6
pubmed: 11400800
Gastroenterology. 2018 Feb;154(3):500-514
pubmed: 29221664
Trop Geogr Med. 1991 Jan-Apr;43(1-2):209-14
pubmed: 1750117
Afr J Med Med Sci. 1996 Mar;25(1):23-9
pubmed: 9110051
Am J Gastroenterol. 2013 Feb;108(2):270-6
pubmed: 23295280
J Gastroenterol Hepatol. 2014 Mar;29(3):474-9
pubmed: 24304041
Aliment Pharmacol Ther. 2007 Feb 15;25(4):477-86
pubmed: 17270004
S Afr Med J. 2015 Nov 06;105(12):1064-9
pubmed: 26792168
Alcohol Health Res World. 1997;21(1):76-83
pubmed: 15706765
Aliment Pharmacol Ther. 2010 May;31(10):1141-51
pubmed: 20175766
Aliment Pharmacol Ther. 2011 Jun;33(11):1215-24
pubmed: 21443537
Aliment Pharmacol Ther. 2001 Feb;15(2):207-16
pubmed: 11148439
Scand J Gastroenterol. 2006 Feb;41(2):149-54
pubmed: 16484119
J Pak Med Assoc. 2012 Jul;62(7):672-6
pubmed: 23866513
Aliment Pharmacol Ther. 2000 Apr;14(4):413-20
pubmed: 10759620
Indian J Gastroenterol. 2000 Apr-Jun;19(2):68-70
pubmed: 10812818
Arch Intern Med. 1998 Jul 13;158(13):1427-33
pubmed: 9665351
Health Qual Life Outcomes. 2009 May 23;7:45
pubmed: 19463190
Middle East J Dig Dis. 2010 Jan;2(1):24-30
pubmed: 25197509
N Engl J Med. 2015 Nov 5;373(19):1853-63
pubmed: 26535514
Am J Gastroenterol. 2000 Jun;95(6):1448-55
pubmed: 10894577

Auteurs

Jean Bosco Bangamwabo (JB)

Department of Internal Medicine, Kibuye Referral Hospital, Kibuye, Rwanda.

John David Chetwood (JD)

Calvary Mater Newcastle, Waratah, New South Wales, Australia.

Vincent Dusabejambo (V)

Department of Internal Medicine, Kigali University Teaching Hospital, Kigali, Rwanda.
Department of Internal Medicine, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Cyprien Ntirenganya (C)

Department of Internal Medicine, University Teaching Hospital of Butare, Butare, Rwanda.

George Nuki (G)

University of Edinburgh, Edinburgh, UK.

Arcade Nkurunziza (A)

Kibungo Hospital, Kibungo, Eastern Province, Rwanda.
Department of Internal Medicine, Kibungo Referral Hospital, Ngoma District, Rwanda.

Kelly A Kieffer (KA)

Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

Michael Jones (M)

Psychology Faculty, Macquarie University, Sydney, New South Wales, Australia.

Timothy D Walker (TD)

Calvary Mater Newcastle, Waratah, New South Wales, Australia timwalkerd@gmail.com.
School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH